Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine and Melatonin Dose Finding for the Correction of the Metabolic Abnormality
Latest Information Update: 01 Mar 2023
At a glance
- Drugs Melatonin (Primary) ; Olanzapine (Primary)
- Indications Bipolar disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 23 Feb 2023 Planned End Date changed from 1 Dec 2023 to 1 Dec 2025.
- 23 Feb 2023 Planned primary completion date changed from 1 Dec 2022 to 1 Dec 2025.
- 08 Jul 2020 Planned End Date changed from 1 Dec 2021 to 1 Dec 2023.